Chemoinformaics analysis of E-6-O-P-METHOXYCINNAMOYL SCANDOSIDE METHYL ESTER
Molecular Weight | 564.54 | nRot | 9 |
Heavy Atom Molecular Weight | 532.284 | nRig | 25 |
Exact Molecular Weight | 564.184 | nRing | 4 |
Solubility: LogS | -1.678 | nHRing | 2 |
Solubility: LogP | 0.301 | No. of Aliphatic Rings | 3 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 72 | No. of Aliphatic Hetero Cycles | 2 |
No. of Heavy Atom | 40 | No. of Aromatic Carbocycles | 1 |
nHetero | 13 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 32 | No. of Saturated Hetero Cycles | 1 |
No. of Carbon atom | 27 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
No. of Oxygen atom | 13 | No. of Arom Bond | 6 |
nHA | 13 | APOL | 76.8534 |
nHD | 5 | BPOL | 44.2546 |
QED | 0.14 |
Synth | 4.786 |
Natural Product Likeliness | 2.112 |
NR-PPAR-gamma | 0.03 |
Lipinski | Rejected |
Pfizer | Accepted |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0.001 |
Pgp-sub | 0.454 |
HIA | 0.978 |
CACO-2 | -5.839 |
MDCK | 0.000122643 |
BBB | 0.519 |
PPB | 0.398338 |
VDSS | 0.388 |
FU | 0.281432 |
CYP1A2-inh | 0.012 |
CYP1A2-sub | 0.053 |
CYP2c19-inh | 0.044 |
CYP2c19-sub | 0.275 |
CYP2c9-inh | 0.011 |
CYP2c9-sub | 0.082 |
CYP2d6-inh | 0.004 |
CYP2d6-sub | 0.199 |
CYP3a4-inh | 0.14 |
CYP3a4-sub | 0.232 |
CL | 1.715 |
T12 | 0.42 |
hERG | 0.051 |
Ames | 0.747 |
ROA | 0.388 |
SkinSen | 0.032 |
Carcinogencity | 0.794 |
EI | 0.006 |
Respiratory | 0.854 |
NR-Aromatase | 0.036 |
Antiviral | Yes |
Prediction | 0.86548 |